NCT04071756View on ClinicalTrials.gov

Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 30, 2019

Primary Completion Date

June 12, 2021

Study Completion Date

July 14, 2022

Conditions
Solid TumorHand-Foot Skin Reaction (HFSR)
Interventions
DRUG

Topical Tazarotene

This medicine works by making the skin less inflamed and reducing the thickness and pain from lesions of the skin

OTHER

Placebo

A substance that has no therapeutic effect, used as a control in testing new drugs

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER